These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 19215985)

  • 1. The use of triiodothyronine as an augmentation agent in treatment-resistant bipolar II and bipolar disorder NOS.
    Kelly T; Lieberman DZ
    J Affect Disord; 2009 Aug; 116(3):222-6. PubMed ID: 19215985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bipolar disorder not otherwise specified in relation to the bipolar spectrum.
    Bader CD; Dunner DL
    Bipolar Disord; 2007 Dec; 9(8):860-7. PubMed ID: 18076535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjunctive stimulant use in patients with bipolar disorder: treatment of residual depression and sedation.
    Carlson PJ; Merlock MC; Suppes T
    Bipolar Disord; 2004 Oct; 6(5):416-20. PubMed ID: 15383134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is adjunctive open-label zonisamide effective for bipolar disorder?
    Ghaemi SN; Shirzadi AA; Klugman J; Berv DA; Pardo TB; Filkowski MM
    J Affect Disord; 2008 Jan; 105(1-3):311-4. PubMed ID: 17586053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is donepezil useful for improving cognitive dysfunction in bipolar disorder?
    Kelly T
    J Affect Disord; 2008 Apr; 107(1-3):237-40. PubMed ID: 17825922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of quetiapine in rapid cycling bipolar disorder: a preliminary study.
    Goldberg JF; Kelley ME; Rosenquist KJ; Hsu DJ; Filkowski MM; Nassir Ghaemi S
    J Affect Disord; 2008 Jan; 105(1-3):305-10. PubMed ID: 17550787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute treatment of bipolar depression with adjunctive zonisamide: a retrospective chart review.
    Baldassano CF; Ghaemi SN; Chang A; Lyman A; Lipari M
    Bipolar Disord; 2004 Oct; 6(5):432-4. PubMed ID: 15383137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Appearance of mania in drug-resistant bipolar depressed patients after treatment with L-triiodothyronine.
    Evans DL; Strawn SK; Haggerty JJ; Garbutt JC; Burnett GB; Pedersen CA
    J Clin Psychiatry; 1986 Oct; 47(10):521-2. PubMed ID: 3759918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary results of a fine-grain analysis of mood swings and treatment modalities of bipolar I and II patients using the daily prospective life-chart-methodology.
    Born C; Seitz NN; Grunze H; Vieta E; Dittmann S; Seemüller F; Amann B
    Acta Psychiatr Scand; 2009 Dec; 120(6):474-80. PubMed ID: 19485960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of bipolar disorder in women with postpartum depression.
    Sharma V; Khan M
    Bipolar Disord; 2010 May; 12(3):335-40. PubMed ID: 20565441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do social anxiety disorder patients belong to a bipolar spectrum subgroup?
    Valença AM; Nardi AE; Nascimento I; Lopes FL; Freire RC; Mezzasalma MA; Veras AB; Versiani M
    J Affect Disord; 2005 May; 86(1):11-8. PubMed ID: 15820266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of thyroid supplements to augment antidepressant medication.
    Joffe RT
    J Clin Psychiatry; 1998; 59 Suppl 5():26-9; discussion 30-1. PubMed ID: 9635545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Creatine monohydrate in resistant depression: a preliminary study.
    Roitman S; Green T; Osher Y; Karni N; Levine J
    Bipolar Disord; 2007 Nov; 9(7):754-8. PubMed ID: 17988366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ziprasidone monotherapy in bipolar II depression: an open trial.
    Liebowitz MR; Salmán E; Mech A; Dunner D; Johnson AE; Akhtar J; Pratap R
    J Affect Disord; 2009 Nov; 118(1-3):205-8. PubMed ID: 19264363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The analysis of bipolar spectrum features in drug resistant unipolar depression patients as compared to depressive patients who responded to standard antidepressant treatment. A pilot study].
    Dudek D; Siwek M; Borowiecka-Kluza J
    Psychiatr Pol; 2008; 42(2):283-94. PubMed ID: 19697533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Mixed hypomania" in children and adolescents: is it a pediatric bipolar phenotype with extreme diurnal variation between depression and hypomania?
    Dilsaver SC; Akiskal HS
    J Affect Disord; 2009 Jul; 116(1-2):12-7. PubMed ID: 19007995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long term augmentation with T3 in refractory major depression.
    Kelly TF; Lieberman DZ
    J Affect Disord; 2009 May; 115(1-2):230-3. PubMed ID: 19108898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The relationships between socio-demographic and clinical data and the bipolar spectrum features in treatment resistant patients. A pilot study].
    Dudek D; Siwek M; Borowiecka-Kluza J
    Psychiatr Pol; 2008; 42(2):295-304. PubMed ID: 19697534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of aggression with risperidone in children and adolescents with bipolar disorder: a case series.
    Saxena K; Chang K; Steiner H
    Bipolar Disord; 2006 Aug; 8(4):405-10. PubMed ID: 16879141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to ECT in bipolar I, bipolar II and unipolar depression.
    Medda P; Perugi G; Zanello S; Ciuffa M; Cassano GB
    J Affect Disord; 2009 Nov; 118(1-3):55-9. PubMed ID: 19223079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.